SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John R Resseger who wrote (223)3/31/1998 4:10:00 PM
From: All Mtn Ski  Read Replies (2) of 548
 
Wow, looks like I missed all the excitement on this Thread! I concur with all your fine points...

To Bob: I don't think anyone expected Oxygent to be approved in 1994, and I don't believe Alliance has been anything but forthcoming in communicating the various stages of development its drugs are in. Someone must have fed you the wrong info. I agree if J&J pulled out this stock would tank, but I don't believe they will. J&J owns a lot of stock at 15 and has met all the royalty payments with each achieved milestone. For J&J, by investing in these Bio-Techs, they expand their pipeline at a much lower cost than going at it themselves...

To John: Short position as of 3/13/98: 817,402, up 8.4% from Feb.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext